A VACCINE designed to block the effects of methamphetamine has been shown to stimulate immune responses in mice, opening the door to a therapeutic option to beat addiction.
Published in the International Journal of Molecular Sciences, Victoria University's Prof Vasso Apostolopoulos and her team's research on the effects of meth on the gut and brains of mice found that just one dose can cause the breakdown of the gut wall.
"These results are significant.
"Given that around 95% of people who go to rehabilitation for meth relapse and use it again, it seemed like a logical next step to develop immunotherapy, which will help them to get over their addiction," Apostolopoulos explained, having developed five different versions of the vaccine currently being tested.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 23
